hypericin has been researched along with nsc185058 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adriaenssens, Y; Augustyns, K; Cleenewerck, M; De Meyer, GRY; Declercq, W; Gladysz, R; Grootaert, MOJ; Joossens, J; Lambeir, AM; Martinet, W; Roelandt, R; Van der Veken, P | 1 |
| Chen, Y; Li, Y; Liu, B; Liu, J; Ouyang, L; Yang, G; Zhao, Y | 1 |
1 review(s) available for hypericin and nsc185058
| Article | Year |
|---|---|
Targeting Atg4B for cancer therapy: Chemical mediators.
Topics: Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Chloroquine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Humans; Imidazoles; Models, Molecular; Molecular Targeted Therapy; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 2021 |
1 other study(ies) available for hypericin and nsc185058
| Article | Year |
|---|---|
Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
Topics: Autophagy; Autophagy-Related Proteins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Electrophoresis; Enzyme Assays; Humans; Temperature | 2016 |